Menu
Back to Browse Categories
Related journals you may be interested in:
Recent articles:
- 10 records -
Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study
Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W
Journal of Hepatocellular Carcinoma 2022, 9:437-451
Published Date: 20 May 2022
Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
Zhang G
Journal of Hepatocellular Carcinoma 2022, 9:423-436
Published Date: 19 May 2022
Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case–Control Study
Rakotomalala JA, Razafindrazoto CI, Randriamifidy NH, Ralaizanaka BM, Maherison S, Hasina Laingonirina DH, Rakotomaharo M, Rasolonjatovo AS, Rakotovao MA, Rakotozafindrabe ALR, Rabenjanahary TH, Fanantenantsoa R, Razafimahefa SH, Ramanampamonjy RM
Hepatic Medicine: Evidence and Research 2022, 14:79-85
Published Date: 18 May 2022
Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia
Tassachew Y, Abebe T, Belyhun Y, Teffera T, Shewaye AB, Desalegn H, Andualem H, Kinfu A, Mulu A, Mihret A, Howe R, Aseffa A
Hepatic Medicine: Evidence and Research 2022, 14:67-77
Published Date: 13 May 2022
Decreased Rate of Presentation, but Worsened Racial-Ethnic Disparity in Acute Gastrointestinal Bleeding During Coronavirus 2019 Shutdown: A Retrospective Cohort Study
Reddy S, Patel B, Baldelli L, Majithia RT, Dougherty MK
Clinical and Experimental Gastroenterology 2022, 15:67-77
Published Date: 10 May 2022
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y
Journal of Hepatocellular Carcinoma 2022, 9:389-403
Published Date: 9 May 2022
RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma
Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L
Journal of Hepatocellular Carcinoma 2022, 9:405-422
Published Date: 9 May 2022
Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P
Journal of Hepatocellular Carcinoma 2022, 9:379-387
Published Date: 5 May 2022
Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells
Zhang C, Xie Y, Lai R, Wu J, Guo Z
Journal of Hepatocellular Carcinoma 2022, 9:367-377
Published Date: 3 May 2022
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
Yoshitani H, Ito J, Kozono H
Hepatic Medicine: Evidence and Research 2022, 14:37-66
Published Date: 2 May 2022